Capital Management Associates Inc’s Merck MRK Stock Holding History

Capital Management Associates Inc’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Buy	14,854 +76	+0.5%	+$8.9K	0.38%	43
2026 Q1	$1.78M	Buy	14,778 +998	+7%	+$115K	0.4%	39
2025 Q4	$1.45M	Buy	13,780 +7,000	+103%	+$657K	0.32%	49
2025 Q3	$569K	Buy	6,780 +580	+9%	+$47.8K	0.15%	75
2025 Q2	$491K	Buy	+6,200	New	+$493K	0.16%	73
2025 Q1	–	Sell	-6,200	Closed	-$617K	–	137
2024 Q4	$617K	Sell	6,200 -101	-2%	-$10.4K	0.23%	53
2024 Q3	$716K	Buy	+6,301	New	+$749K	0.29%	49

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Capital Management Associates Inc's MRK Position: Q2 2026 in Review

Capital Management Associates Inc increased its Merck (MRK) stake by 0.51% in Q2 2026, buying an estimated $8.9K and bringing the position to 14,854 shares worth $1.91M. The position accounts for 0.38% of the portfolio, ranked #43.

Capital Management Associates Inc first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Capital Management Associates Inc held 14,854 shares of Merck worth $1.91M as of Q2 2026.
Capital Management Associates Inc bought 76 Merck shares in Q2 2026, an estimated $8.9K.
Merck made up 0.38% of Capital Management Associates Inc's portfolio in Q2 2026, its #43 holding.
Capital Management Associates Inc first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capital Management Associates Inc's 13F filing for Q2 2026, filed 22 Jul 2026.